Precision Oncology Drug Shows Power Of Cancer Genomics

  The key to the positive results is molecular matching. Patients received larotrectinib, a TRK inhibitor, only if their cancers were marked by a switch…It’s a perfect example of how precision medicine can benefit patients with rare conditions.

The Big News For Sickle Cell Anemia Is Not Gene Therapy

Blood specialists reported on practice-changing studies for sickle cell disease, including a large study of bone marrow transplant from matched sibling donors. A preliminary report looked at effects of GBT440, a novel oral agent that augments hemoglobin’s binding to oxygen.

Five Key Issues For The Future Of Cancer IT

If there’s one thing that’s become clear about precision medicine – and the delivery of optimal care based in science – it will require super technology. This need is especially urgent in oncology.